End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,020 KRW | +9.54% | -.--% | -67.58% |
16/05 | NKMAX CO., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | NKMAX CO., Ltd. cancelled the transaction announced on October 20, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
125M | - | - | - | - | - | |
124B | ||||||
109B | ||||||
23.84B | - | |||||
22.42B | - | |||||
17.5B |
- Stock Market
- Equities
- A182400 Stock
- Charts NKMAX CO., Ltd.
- Sector Chart